Another study found that MDM2 enhances recombinant heat shock transcription factor 1 (HSF1) ubiquitination and inhibits NLRP3, which activates inflammatory vesicles and boosts NAFLD and IR (129). Here, HSF1 is linked to metabolic dysfunction-associated steatotic liver disease.